This combined effect was more apparent in the early phase of infection (first two weeks of symptom onset) which could be associated with development of an NP- or RBD-specific IgA immune response in the early phase of infection and late development of IgM and IgG responses [112,113]. The gene discussed is CD79A; the disease is infection.